| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4007603 | Archivos de la Sociedad Española de Oftalmología | 2011 | 5 Pages |
Abstract
Intravitreal bevacizumab can be an alternative treatment in patients with serous central chorioretinopathy as it leads to a better objective visual acuity and foveal thickness with optical coherence tomography.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
I. Gregori-Gisbert, F. Aguirre-Balsalobre, J. GarcÃa-Sánchez, G. León-Salvatierra, E. Mengual-Verdú, J.R. Hueso-Abancéns,